[Case report; a thromboembolic event in a patient with antiphospholipid antibody associated thrombocytopenia during eltrombopag therapy].
Department of Rheumatology and Clinical Immunology, Sapporo City General Hospital, Japan.
Masatoshi
M
Kanda
Makoto
M
Kondo
Satoshi
S
Yamamoto
Masaya
M
Mukai
D000368:Aged; D017152:Antibodies, Antiphospholipid / Q000097:blood*; D001565:Benzoates / Q000009:adverse effects*; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D006834:Hydrazines / Q000009:adverse effects*; D011720:Pyrazoles / Q000009:adverse effects*; D013921:Thrombocytopenia / Q000175:diagnosis / Q000188:drug therapy*; D013923:Thromboembolism / Q000139:chemically induced* / Q000175:diagnosis; D016896:Treatment Outcome; D014859:Warfarin / Q000627:therapeutic use
D017152:Antibodies, Antiphospholipid; D001565:Benzoates; D006834:Hydrazines; D011720:Pyrazoles; D014859:Warfarin; D006493:Heparin; C520809:eltrombopag